Supervised, vigorous intensity exercise intervention for depressed female smokers: A pilot study

Nicotine and Tobacco Research

Volumn 19, Issue 1, 2017, Pages 77-86

  Patten, Christi A ^a   Bronars, Carrie A ^a   Douglas, Kristin S Vickers ^a   Ussher, Michael H ^b   Levine, James A ^c   Tye, Susannah J ^d   Hughes, Christine A ^a   Brockman, Tabetha A ^a   Decker, Paul A ^a   DeJesus, Ramona S ^a   Williams, Mark D ^a   Olson, Thomas P ^a   Clark, Matthew M ^a   Dieterich, Angela M ^d  

^a MAYO CLINIC   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c MAYO CLINIC   (United States)

^d Rochester Area Family YMCA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; NICOTINE PATCH; TUMOR NECROSIS FACTOR; NICOTINE GUM;

ADULT; ARTICLE; BEHAVIOR THERAPY; BODY HEIGHT; BODY WEIGHT; CARDIORESPIRATORY FITNESS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE SEVERITY; EXERCISE INTENSITY; FEMALE; HEALTH EDUCATION; HUMAN; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT HEALTH QUESTIONNAIRE 9; PHYSICAL ACTIVITY; PILOT STUDY; PROGRAM FEASIBILITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION PROGRAM; SMOKING HABIT; THERAPY EFFECT; TOBACCO DEPENDENCE; TREATMENT DURATION; ADOLESCENT; COST BENEFIT ANALYSIS; COUNSELING; FEASIBILITY STUDY; KINESIOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PREVENTION AND CONTROL; PROCEDURES; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; COUNSELING; DEPRESSION; DIAGNOSIS, DUAL (PSYCHIATRY); EXERCISE THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PILOT PROJECTS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85014089264     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw208     Document Type: Article

References (82)

1. Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2005-2014. MMWR Morb Mortal Wkly Rep. 2015;64(44):1233-1240.
2. Piper ME, Cook JW, Schlam TR, et al. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res. 2010;12(6):647-657. doi:10.1093/ntr/ ntq067.
3. Scharf D, Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR. Addiction. 2004;99(11):1462-1469. doi:10.1111/j.1360-0443.2004.00845.x.
4. Perkins KA. Smoking cessation in women. Special considerations. CNS Drugs. 2001;15(5):391-411.
5. Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. J Womens Health (Larchmt). 2007;16(8):1211-1218.
6. Jessup MA, Dibble SL, Cooper BA. Smoking and behavioral health of women. J Womens Health (Larchmt). 2012;21(7):783-791. doi:10.1089/ jwh.2011.2886.
7. Burgess DJ, Fu SS, Noorbaloochi S, et al. Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy. Nicotine Tob Res. 2009;11(12):1439-1447. doi:10.1093/ntr/ ntp158.
8. Japuntich SJ, Leventhal AM, Piper ME, et al. Smoker characteristics and smoking-cessation milestones. Am J Prev Med. 2011;40(3):286-294. doi:10.1016/j.amepre.2010.11.016.
9. Sonne SC, Nunes EV, Jiang H, Tyson C, Rotrosen J, Reid MS. The relationship between depression and smoking cessation outcomes in treatment- seeking substance abusers. Am J Addict. 2010;19(2):111-118. doi:10.1111/j.1521-0391.2009.00015.x.
10. Passey M, Bonevski B. The importance of tobacco research focusing on marginalized groups. Addiction. 2014;109(7):1049-1051. doi:10.1111/ add.12548.
11. Williams JM, Steinberg ML, Griffiths KG, Cooperman N. Smokers with behavioral health comorbidity should be designated a tobacco use disparity group. Am J Public Health. 2013;103(9):1549-1555. doi:10.2105/ AJPH.2013.301232.
12. Vickers KS, Patten CA, Lewis BA, et al. Feasibility of an exercise counseling intervention for depressed women smokers. Nicotine Tob Res. 2009;11(8):985-995. doi:10.1093/ntr/ntp101.
13. Bernard P, Ninot G, Cyprien F, et al. Exercise and counseling for smoking cessation in smokers with depressive symptoms: a randomized controlled pilot trial. J Dual Diagn. 2015;11(3-4):205-216. doi:10.1080/15504263. 2015.1113842.
14. Brown RA, Abrantes AM, Strong DR, et al. Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers. Nicotine Tob Res. 2014;16(2):197-207. doi:10.1093/ntr/ntt134.
15. Evins AE, Culhane MA, Alpert JE, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008;28(6):660-666. doi:10.1097/JCP.0b013e31818ad7d6.
16. Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Public Health. 2006;96(10):1808-1814. doi:10.2105/ AJPH.2005.080382.
17. MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 2010;78(1):55-61. doi:10.1037/a0017939.
18. Ussher MH, Taylor AH, Faulkner GE. Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2014;8:CD002295. doi:10.1002/14651858.CD002295.pub5.
19. Marcus BH, Albrecht AE, King TK, et al. The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial. Arch Intern Med. 1999;159(11):1229-1234.
20. Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69(7):587-596. doi:10.1097/PSY.0b013e318148c19a.
21. Whiteley JA, Williams DM, Dunsiger S, et al. YMCA commit to quit: randomized trial outcomes. Am J Prev Med. 2012;43(3):256-262. doi:10.1016/j.amepre.2012.05.025.
22. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005;28(1):1-8.
23. Singh NA, Stavrinos TM, Scarbek Y, Galambos G, Liber C, Fiatarone Singh MA. A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci. 2005;60(6):768-776.
24. Perraton LG, Kumar S, Machotka Z. Exercise parameters in the treatment of clinical depression: a systematic review of randomized controlled trials. J Eval Clin Pract. 2010;16(3):597-604. doi:10.1111/j.1365-2753.2009.01188.x.
25. Galper DI, Trivedi MH, Barlow CE, Dunn AL, Kampert JB. Inverse association between physical inactivity and mental health in men and women. Med Sci Sports Exerc. 2006;38(1):173-178.
26. Hollenberg M, Haight T, Tager IB. Depression decreases cardiorespiratory fitness in older women. J Clin Epidemiol. 2003;56(11):1111-1117.
27. Lavoie KL, Fleet RP, Lespérance F, et al. Are exercise stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder? Am Heart J. 2004;148(4):621-627.
28. Marcus BH, Lewis BA, Hogan J, et al. The efficacy of moderate-intensity exercise as an aid for smoking cessation in women: a randomized controlled trial. Nicotine Tob Res. 2005;7(6):871-880.
29. Williams DM. Increasing fitness is associated with fewer depressive symptoms during successful smoking abstinence among women. Int J Fit. 2008;4(1):39-44.
30. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U. S. Department of Health and Human Services. Public Health Service; 2008.
31. Appleton AA, Buka SL, Loucks EB, Gilman SE, Kubzansky LD. Divergent associations of adaptive and maladaptive emotion regulation strategies with inflammation. Health Psychol. 2013;32(7):748-756. doi:10.1037/ a0030068.
32. Walker AJ, Kim Y, Price JB, et al. Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention. Front Psychiatry. 2014;5:34. doi:10.3389/fpsy.2014.00034.
33. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171-186. doi:10.1097/PSY.0b013e3181907c1b.
34. Karatsoreos IN, McEwen BS. Psychobiological allostasis: resistance, resilience and vulnerability. Trends Cogn Sci. 2011;15:576-584. doi:10.1016/j. tics.2011.10.005.
35. Maes M, Yirmyia R, Noraberg J, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009;24(1):27-53. doi:10.1007/s11011-008-9118-1.
36. Yanbaeva DG, Dentener MA, Creutzberg EC, Wouters EF. Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD. 2006;3(1):51-61.
37. Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199-229. doi:10.1016/j.neuroscience.2013.04.060.
38. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732-741. doi:10.1016/j.biopsych.2008.11.029.
39. Pedersen BK, Fischer CP. Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007;28(4):152-156.
40. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694-696.
41. Czajkowski SM, Powell LH, Adler N, et al. From ideas to efficacy: the ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol. 2015;34(10):971-982. doi:10.1037/hea0000161.
42. Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from stage I. Clin Psychol Sci Pract. 2001;8(2):133-142. doi:10.1093/clipsy.8.2.133.
43. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry. 2006;59(11):990-996. doi:10.1016/j.biopsych.2005.09.014.
44. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33; quiz 34-57.
45. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.
46. McCrady-Spitzer SK, Manohar CU, Koepp GA, Levine JA. Low-cost and scalable classroom equipment to promote physical activity and improve education. J Phys Act Health. 2015;12(9):1259-1263. doi:10.1123/ jpah.2014-0159.
47. Cole JC, Rabin AS, Smith TL, Kaufman AS. Development and validation of a Rasch-derived CES-D short form. Psychol Assess. 2004;16(4): 360-372. doi:10.1037/1040-3590.16.4.360.
48. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1081-1093. doi:10.1161/CIRCULATIONAHA.107.185649.
49. Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci. 1992;17(4):338-345.
50. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509-515. doi:10.3928/0048-5713-20020901-06.
51. Annesi JJ, Gorjala S. Association of reduction in waist circumference with normalization of mood in obese women initiating exercise supported by the Coach Approach protocol. South Med J. 2010;103(6):517-521. doi:10.1097/SMJ.0b013e3181de0eb5.
52. Chapman LS, Lesch N, Baun MP. The role of health and wellness coaching in worksite health promotion. Am J Health Promot. 2007;21(6):suppl. 1-10, iii.
53. Mettler EA, Preston HR, Jenkins SM, et al. Motivational improvements for health behavior change from wellness coaching. Am J Health Behav. 2014;38(1):83-91. doi:10.5993/AJHB.38.1.9.
54. McPherson K, Bronars C, Patten C, et al. Understanding word preference for description of exercise interventions as a means for enhancing recruitment and acceptability of exercise treatment among adults treated for depression. Ment Health Phys Act. 2014;7(2):73-77. doi:10.1016/j. mhpa.2014.05.001.
55. Borg GA. Perceived exertion. Exerc Sport Sci Rev. 1974;2:131-153.
56. Ussher M, Lewis S, Aveyard P, et al. Physical activity for smoking cessation in pregnancy: randomised controlled trial. BMJ. 2015;350:h2145. doi:10.1136/bmj.h2145.
57. Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143-164. doi:10.1177/1090198104263660.
58. Marcus BH, Forsyth LH. Motivating People to be Physically Active. 2nd ed. Champaign, IL: Human Kinetics; 2009.
59. Patten CA, Armstrong CA, Martin JE, Sallis JF, Booth J. Behavioral control of exercise in adults: studies 7 and 8. Psychol Health. 2000;15(4): 571-581. doi:10.1080/08870440008402014.
60. Redfield MM, Anstrom KJ, Levine JA, et al. Isosorbide mononitrate in heart failure with preserved ejection fraction. N Engl J Med. 2015;373(24):2314-2324. doi:10.1056/NEJMoa1510774.
61. Prochaska JJ, Hall SM, Humfleet G, et al. Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial. Prev. Med. 2008;47(2):215-220. doi:10.1016/j.ypmed.2008.05.006.
62. Bellg AJ, Borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443-451. doi:10.1037/0278-6133.23.5.443.
63. Waltz J, Addis ME, Koerner K, Jacobson NS. Testing the integrity of a psychotherapy protocol: assessment of adherence and competence. J Consult Clin Psychol. 1993;61(4):620-630.
64. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine Tob Res. 2012;14(1):75-78. doi:10.1093/ntr/ntr137.
65. Mercer SW, McConnachie A, Maxwell M, Heaney D, Watt GC. Relevance and practical use of the Consultation and Relational Empathy (CARE) measure in general practice. Fam Pract. 2005;22(3):328-334. doi:10.1093/ fampra/cmh730.
66. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159. doi:10.1080/14622200210123581.
67. Cooke F, Bullen C, Whittaker R, McRobbie H, Chen MH, Walker N. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res. 2008;10(4):607-612. doi:10.1080/14622200801978680.
68. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13-25.
69. Keller-Ross ML, Johnson BD, Carter RE, et al. Improved ventilatory efficiency with locomotor muscle afferent inhibition is strongly associated with leg composition in heart failure. Int J Cardiol. 2015;202:159-166. doi:10.1016/j.ijcard.2015.08.212.
70. Olson TP, Joyner MJ, Eisenach JH, Curry TB, Johnson BD. Influence of locomotor muscle afferent inhibition on the ventilatory response to exercise in heart failure. Exp Physiol. 2014;99(2):414-426. doi:10.1113/expphysiol.2013.075937.
71. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
72. Löwe B, Kroenke K, Herzog W, Grafe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(1):61-66. doi:10.1016/S0165-0327(03)00198-8.
73. Löwe B, Unützer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42(12):1194-1201.
74. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3): 299-303. doi:10.1111/j.1360-0443.2004.00995.x.
75. Stanton R, Reaburn P. Exercise and the treatment of depression: a review of the exercise program variables. J Sci Med Sport. 2014;17(2):177-182. doi:10.1016/j.jsams.2013.03.010.
76. Maddison R, Roberts V, McRobbie H, et al. Exercise counseling to enhance smoking cessation outcomes: the Fit2Quit randomized controlled trial. Ann Behav Med. 2014;48(2):194-204. doi:10.1007/ s12160-014-9588-9.
77. Bize R, Willi C, Chiolero A, et al. Participation in a population-based physical activity programme as an aid for smoking cessation: a randomised trial. Tob Control. 2010;19(6):488-494. doi:10.1136/tc.2009.030288.
78. Boecker H, Henriksen G, Sprenger T, et al. Positron emission tomography ligand activation studies in the sports sciences: measuring neurochemistry in vivo. Methods. 2008;45(4):307-318. doi:10.1016/j. ymeth.2008.07.003.
79. Boecker H, Sprenger T, Spilker ME, et al. The runner's high: opioidergic mechanisms in the human brain. Cereb Cortex. 2008;18(11):2523-2531. doi:10.1093/cercor/bhn013.
80. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748-751. doi:10.1176/appi. ajp.2010.09091379.
81. Muench F, van Stolk-Cooke K, Morgenstern J, Kuerbis AN, Markle K. Understanding messaging preferences to inform development of mobile goal-directed behavioral interventions. J Med Internet Res. 2014;16(2):e14. doi:10.2196/jmir.2945.
82. Fanning J, Mullen SP, McAuley E. Increasing physical activity with mobile devices: a meta-analysis. J Med Internet Res. 2012;14(6):e161. doi:10.2196/jmir.2171.